• Markets
    • icon
  • Companies
CMP · ASX

Compumedics Limited (ASX:CMP)

AU$0.23

 0.0 (0.0%)
ASX:Live
05/12/2023 03:52:12 PM
HALO Price Momentum HALO Ords GROWTH AUS Engulfing Bearish Big Candle +1
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

CMP Overview

CMP Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About CMP

Website

Compumedics Limited

Telephone

61.3.8420.7300

Address

30-40 Flockhart Street Abbotsford, Victoria (VIC) 3067

Description

Compumedics Ltd. is engages in the research, development, manufacture and distribution of medical equipment. It offers innovative computer based diagnostic technologies in the areas of sleep, neurology and cardiology. The firm operates through the following geographical segments: United States of America, Australia and Asia Pacific, and Europe. The company was founded by Burton David in 1987 and is headquartered in Abbotsford, Australia.

CMP Price Chart

Key Stats

Market Cap

AU$44.29M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.14 - 0.34

Trade Value (12mth)

AU$1,462.00

1 week

31.43%

1 month

21.05%

YTD

15%

1 year

0%

All time high

0.96

Key Fundamentals

EPS 3 yr Growth

4.800%

EBITDA Margin

-5.90%

Operating Cashflow

$0m

Free Cash Flow Return

0.20%

ROIC

-27.90%

Interest Coverage

-3.90

Quick Ratio

0.90

Other Data

Shares on Issue (Fully Dilluted)

177m

HALO Sector

Healthcare

Next Company Report Date

02-Sep-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

CMP Announcements

Latest Announcements

Date Announcements

31 October 23

Chair's Address to Shareholders

×

Chair's Address to Shareholders

31 October 23

Results of Meeting

×

Results of Meeting

31 October 13

AGM Presentation

×

AGM Presentation

31 March 22

Director Appointment/Resignation

×

Director Appointment/Resignation

31 August 16

September Roadshow 2016 Presentation

×

September Roadshow 2016 Presentation

30 September 22

Annual Report to shareholders

×

Annual Report to shareholders

30 September 19

Annual Report to shareholders - Non financial section

×

Annual Report to shareholders - Non financial section

30 September 11

Annual Report to shareholders

×

Annual Report to shareholders

30 September 10

Annual Report to shareholders

×

Annual Report to shareholders

30 September 10

Amended Annual Report to shareholders

×

Amended Annual Report to shareholders

30 September 09

Annual Report to shareholders

×

Annual Report to shareholders

30 September 09

Annual Report to shareholders Financial Section

×

Annual Report to shareholders Financial Section

30 September 09

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

30 September 09

Amendment

×

Amendment

30 October 14

AGM presentation

×

AGM presentation

30 October 14

Annual Report Correction

×

Annual Report Correction

30 August 23

Preliminary Final Report

×

Preliminary Final Report

30 August 23

Business Update June 2023

×

Business Update June 2023

30 August 07

Compumedics 2007 Year-end Presentation

×

Compumedics 2007 Year-end Presentation

29 September 22

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

29 September 21

Full Year Statutory Accounts - Annual Report

×

Full Year Statutory Accounts - Annual Report

29 September 21

Notice of Annual General Meeting

×

Notice of Annual General Meeting

29 September 14

Annual Report to shareholders

×

Annual Report to shareholders

29 April 15

Broker Presentation May 2015

×

Broker Presentation May 2015

28 September 23

Full Year Statutory Accounts

×

Full Year Statutory Accounts

28 September 23

Notice of General Meeting/Proxy Form

×

Notice of General Meeting/Proxy Form

28 September 21

Corporate Presentation Oct 2021

×

Corporate Presentation Oct 2021

28 October 21

AGM Presentation

×

AGM Presentation

CMP Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.01 0.01 -0.03 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.01 0.01 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock 117.0 37.5 -549.4 Lock Lock Lock
     PE X Lock Lock Lock Lock 53.9 N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 0.0 N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.01 0.02 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.01 0.02 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 15.1 28.8 -156.8 Lock Lock Lock
     Yield % Lock Lock Lock Lock 1.7 9.7 -2.7 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.0 N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.13 0.13 0.10 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.10 0.10 0.07 Lock Lock Lock
     Growth % Lock Lock Lock Lock -5.0 -5.2 -29.7 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 177 177 177 Lock Lock Lock
Basic m Lock Lock Lock Lock 177 177 177 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 36 38 42 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1.9 5.6 12.3 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 19 19 25 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 19 19 22 Lock Lock Lock
     Growth % Lock Lock Lock Lock 6.4 0.8 11.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 53.6 51.2 50.9 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 46 49 49 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 2 1 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock 104.3 -27.3 -286.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 5.2 3.6 -5.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 0 0 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 152.6 -65.6 -2,679.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 1.1 0.4 -8.3 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 1 2 -7 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 1 1 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock 117.1 36.0 -551.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock 2.8 3.6 -14.4 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 1 3 0 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 2 3 4 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -2 -3 -4 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 2 -1 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 1 3 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -76.7 130.1 -132.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.0 0.1 -0.0 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 7 7 4 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 39 42 41 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 0 2 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -1 -1 6 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 16 18 23 Lock Lock Lock
Equity $m Lock Lock Lock Lock 22 24 18 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 23 24 20 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1.2 4.7 -17.2 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 2.6 3.3 -14.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 4.5 5.8 -33.5 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 1.5 0.5 -12.2 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 4.4 5.8 -27.9 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 5.8 14.0 0.2 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 5.6 3.4 -3.9 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -0.5 -0.6 -2.2 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -4.3 -3.2 31.0 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 2.1 1.9 1.4 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.4 1.4 0.9 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 21.2 21.7 12.9 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 8.6 18.7 0.2 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 2.5 2.4 2.7 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 1.8 1.9 2.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 2.2 2.4 5.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 12.4 12.5 12.4 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.9 0.9 1.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.9 0.9 1.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 2.2 4.5 -15.8 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 2.0 4.1 -16.3 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock -28.6 20.1 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 2.6 3.3 -14.9 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.7 1.8 2.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 4.5 5.8 -33.5 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 4.5 5.8 -33.5 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 203.8 191.9 178.8 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 148.7 154.8 135.9 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 352.5 346.7 314.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 77.2 90.8 83.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 275.3 255.9 231.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

CMP Shortsell

Frequently Asked Questions

The current share price of Compumedics Limited (CMP:ASX) is AU$0.23.
The 52-week high share price for Compumedics Limited (CMP:ASX) is AU$0.34.
The 52-week low share price for Compumedics Limited (CMP:ASX)? is AU$0.14.
Compumedics Limited (CMP:ASX) does not pay a dividend.
The last dividend payment of Compumedics Limited (CMP:ASX) is AU$0.01.
Compumedics Limited (CMP:ASX) has a franking level of 0%.
Compumedics Limited (CMP:ASX) is classified in the Healthcare.
The current P/E ratio for Compumedics Limited (CMP:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.